Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F.I.R.E. Study: FX06 for cardioprotection in primary PCI for acute myocardial infarction
2006-000619-51Phase 2Completed
- Sponsor
- Fibrex Medical Inc.
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing FX06 with Placebo (2 arms). Primary endpoint: Final infarct size at 5 days. Started May 2006; status: completed.
02
Drugs
FX06
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-000619-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000619-51.